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Edited by Felix WielandAbstract Several biochemical reactions and processes of cell
biology are compartmentalized in the endoplasmic reticulum
(ER). The view that the ER membrane is basically a scaﬀold
for ER proteins, which is permeable to small molecules, is incon-
sistent with recent ﬁndings. The luminal micro-environment is
characteristically diﬀerent from the cytosol; its protein and glu-
tathione thiols are remarkably more oxidized, and it contains a
separate pyridine nucleotide pool. The substrate speciﬁcity and
activity of certain luminal enzymes are dependent on selective
transport of possible substrates and co-factors from the cytosol.
Abundant biochemical, pharmacological, clinical and genetic
data indicate that the barrier function of the lipid bilayer and
speciﬁc transport activities in the membrane make the ER a sep-
arate metabolic compartment.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lumen1. Introduction
The endoplasmic reticulum (ER) is a continuous membrane
network [1] in the cytosol. Its closed internal compartment, the
ER lumen, can comprise about 10% of the total cell volume.
Several metabolic pathways are compartmentalized in the
ER. In particular, the active center of participating enzymes
is localized in the lumen. These pathways are related to carbo-
hydrate metabolism, biotransformation, steroid metabolism
and protein processing [2]. The involved enzymes often receive
their substrates and cofactors from, or release their productsAbbreviations: ER, endoplasmic reticulum; GSH, glutathione; GSSG,
glutathione disulﬁde; GSD 1, glycogen storage disease type 1; CRD,
cortisone reductase deﬁciency; G6P, glucose-6-phosphate; G6Pase,
glucose-6-phosphatase; G6PT, glucose-6-phosphate transporter;
H6PDH, hexose-6-phosphate dehydrogenase; 11bHSDH1, 11b-hydr-
oxysteroid dehydrogenase type 1; MHC, major histocompatibility
complex; RER, rough endoplasmic reticulum; TAP, transporter ass-
ociated with antigen processing; UGA, UDP-glucuronic acid; UGT,
UDP-glucuronosyltransferase
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doi:10.1016/j.febslet.2006.03.050to, the cytosol. Therefore, passage of those compounds across
the ER membrane is indispensable.
There is still a debate whether the ER lumen can be consid-
ered as a separate metabolic compartment, or it is just a site in
the cytosol for some enzymatic reactions. Because of the con-
tinuous inward and outward traﬃc of a large number of mol-
ecules, some scientists conclude that the ER membrane is
permeable to all the small compounds, and acts only as a
cheesecloth to keep the luminal proteins together. However,
this view is contradicted by convincing experimental and clin-
ical evidence indicating that the ER membrane forms a real
barrier to several substances and that the trans-membrane
transport is selective. In fact, the pattern of compounds that
cannot enter or leave the lumen is just as important a determi-
nant of the ER metabolism as the pattern of compounds that
can. The characteristic micro-environment of the ER lumen
could hardly been maintained if passive diﬀusion, driven by
the gradients, eﬀectively equalized the concentrations on the
two sides of the membrane. The most important arguments
for, and against, the general permeability of the ER membrane
are summarized in Table 1.
Which are the most relevant in vivo observations that sup-
port the barrier function of the ER membrane? The two best
studied gradients across the ER membrane are related to the
calcium homeostasis and the oxidative protein folding. Com-
pared to the cytosol, the ER lumen has about four orders of
magnitude higher level of free calcium ion [3] and nearly a hun-
dred times lower ratio of glutathione (GSH) and oxidized glu-
tathione disulﬁde (GSSG) [4]. Although the generation of these
gradients is largely dependent on the poor permeability of the
ER membrane to calcium ion and GSH, they are maintained
or created by continuous active processes, such as pumping
of calcium [3] and luminal oxidation of thiols [5], respectively.
It is, therefore, arguable that high-capacity active processes
surpass the velocity of passive trans-membrane ﬂuxes.
The strongest evidence for separation of the cytosolic and
endoplasmic compartments were provided by genetic analysis
of two ER-related human syndromes, namely the glycogen stor-
age disease type 1 (GSD1) and the cortisone reductase deﬁciency
(CRD). The former proved that glucose 6-phosphate (G6P) is
unable to enter the ER lumen, unless it is mediated by a speciﬁc
transporter, while the latter revealed that the luminal cortisone
reduction is dependent on local NADPH generation, because
the cytosolic and the endoplasmic pyridine nucleotide pools
are separated. GSD 1 refers to inborn deﬁciency of glucose 6-
phosphatase (G6Pase) activity, which causes a complex meta-blished by Elsevier B.V. All rights reserved.
Table 1
Argument over a general permeability of the ER membrane
Pros
 Membrane composition
Low cholesterol and high protein content might increase leakiness by making the membrane structure less ordered [43]
 Translocon
Transiently open transmembrane tunnel may allow non-selective ﬂuxes [40,42]
 Size-dependence
Chemical modiﬁcation of intraluminal proteins by biotin-derivatives of diﬀerent size up to 5 kDa indicate that compounds of a wide range of
molecular weight have free access to the luminal compartment [44]
Cons
 Selectivity
The ER membrane is permeable to certain molecules (e.g. G6P [8,45], dehydroascorbate [26,27], FAD [5,25]) while impermeable to
compounds of very similar size, structure, charge and polarity (e.g. other hexose phosphates [8,13], ascorbate [26,27], pyridine nucleotides
[16,18,19], respectively)
 Exclusion
Several intraluminal enzyme activities are nearly 100% latent in intact microsomes or in intact in situ ER [30,32,33]
 Entrapment
Some compounds generated in the lumen accumulate at remarkable concentrations (e.g. GSSG [22,23], ascorbate [26], glucose [45],
6-phosphogluconate [9]). Concentration gradients can also be maintained by active transport (e.g. Ca2+). Calcium entrapment is enhanced
by the intraluminal G6Pase activity [46]
 Inhibitors
Transmembrane ﬂuxes can be hampered by speciﬁc (e.g. chlorogenic acid derivatives in case of G6PT [47,48]) or general (e.g.
4,4 0-diisothiocyanostilbene-2,2 0-disulfonic acid [23,25,26,36,48]) transport inhibitors
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ver [6]. Besides the defects of G6Pase enzyme itself (GSD 1a),
mutations in a diﬀerent gene were proven to cause similar meta-
bolic disturbances combinedwith some additional symptoms [7]
– a disease called GSD 1b. The protein encoded by this other
gene turned out to be the glucose 6-phosphate transporter
(G6PT), which is apparently needed for the access of the luminal
G6Pase to its substrate [7–9].CRD is basedon insuﬃcient reduc-
tion of cortisone to cortisol by 11b-hydroxysteroid dehydroge-
nase type 1 (11bHSDH1) in the ER lumen. The mutation
analyses showed that this phenotype is caused by the combined
defects of 11bHSDH1 and hexose 6-phosphate dehydrogenase
(H6PDH) [10]. This ﬁnding indicates that the luminal generation
of NADPHbyH6PDH (rather than cytosolic NADPHproduc-
tion) drives the cortisone reduction in physiological conditions.
This conclusionwas validated by the results obtained inH6PDH
knockout mice [11].
Hereafter this review summarizes the elucidated role of the
ER membrane (as a barrier with selective transport) in the best
studied metabolic systems of the ER.2. G6Pase system
Hydrolysis of G6P is the common ultimate step of glucose
production from glycogen breakdown or gluconeogenesis in li-
ver and kidney. The reaction is catalyzed by G6Pase, an inte-
gral membrane protein of the ER with intraluminal active
center [8]. The system, therefore, theoretically comprises three
transporters (for G6P, glucose and phosphate) associated
functionally to the enzyme activity [8] (Fig. 1). One of the par-
ticipating transporters, G6PT has been identiﬁed at molecular
level [7,9]. Glucose and galactose transport across the ER
membrane has been recently investigated in situ by usinggenetically encoded ﬂuorescence resonance energy transfer
nanosensors [12]. Although the speciﬁc glucose transporter still
remains to be identiﬁed, it was concluded that the remarkable
diﬀerences in the kinetics strongly argue against the presence of
a non-selective pore.
Intact membrane barrier is an important determinant of the
physiological characteristics of G6Pase. Permeabilization of
microsomal vesicles only doubles the rate of G6P hydrolysis
whilst it causes a 10–15-fold enhancement of the hydrolysis of
mannose 6-phosphate and various other sugar phosphates,
which become as good substrates of the enzyme as G6P [13].
Similar results were obtained using in situ permeabilized ER
membranes [14,15]. The high substrate speciﬁcity of G6Pase in
physiological conditions, therefore, relies on the selective trans-
port ofG6P into the lumen ofERand is not an intrinsic property
of the enzyme. It is vitally important that the ERmembrane sep-
arates the unselective G6Pase from the phosphoester intermedi-
ates of glycolysis/gluconeogenesis and amino sugarmetabolism.
The metabolic derangements in GSD 1a (G6Pase deﬁciency)
and GSD 1b (G6PT deﬁciency) are indistinguishable and
based in both cases on insuﬃcient G6Pase activity [6]. This fact
is evidently inconsistent with the theory of an un-speciﬁcally
permeable ER membrane.3. H6PDH and 11b-HSDH1
11bHSDH1 catalyzes reversible interconversion of cortisone
and cortisol in the lumen of the ER (Fig. 1). The predominant
in vivo direction is cortisone reduction, which is driven by a
high luminal [NADPH]/[NADP+] ratio. The high ratio can
be maintained by luminal dehydrogenases, such as H6PDH
[9,16,17], because the permeability of the ER membrane to
pyridine nucleotides is insigniﬁcant [18,19].
Fig. 1. ER, a metabolic compartment. Certain luminal enzyme systems include transport activities importing their substrates and cofactors or
exporting their products. Transporters may narrow the substrate speciﬁcity of the luminal catalytic subunits (e.g. G6Pase) [8] and/or determine the
reaction rate (e.g. UGTs) [32]. The luminal localization of glucuronidation and de-glucuronidation necessitates translocation of substrates and
glucuronides of various size and structure [30,34,35]. Separate, ER-speciﬁc redox of a pyridine nucleotide pool can be maintained by co-operating
intraluminal enzyme activities (H6PDH, 11bHSDH) [10,16,17]. The protein facilitating G6P transport across the ER membrane has been identiﬁed
[7]. Ovals and circles represent enzymes and transporters, respectively. GA, glucuronate; G6P, glucose-6-phosphate; G6PT, glucose-6-phosphate
transporter; G6Pase, glucose-6-phosphatase; GUS, microsomal b-glucuronidase; H6PDH, hexose 6-phosphate dehydrogenase; 11bHSDH1, 11b-
hydroxysteroid dehydrogenase type 1; UGA, UDP-glucuronate; UGT UDP-glucuronosyltransferase; X-OH, aglycone (various); X-GA, aglycone-
glucuronide (various).
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NADPH can penetrate the ER membrane in long incubations
and that also the cytosolic [NADPH]/[NADP+] ratio can aﬀect
11bHSDH1 activity [20]. Nevertheless, H6PDH knockout
mice lack 11bHSDH1 mediated glucocorticoid generation
[11], which proves that the enzyme cannot rely on cytosolic
NADPH resources and a separate luminal pyridine nucleotide
pool exists. It also clearly shows that the high luminal
[NADPH]/[NADP+] ratio is dependent on the H6PDH activity
and – consequently – on transport of G6P across the ER mem-
brane (Fig. 1).
In fact, substrate speciﬁcity of H6PDH is largely dependent
on its localization in the ER. This enzyme has dehydrogenase
activity on various hexose 6-phosphates, such as G6P, galac-
tose 6-phosphate or 2-deoxyglucose 6-phosphate and on sim-
ple sugars such as glucose and it also has dual nucleotide
speciﬁcity for NADP+ and NAD+. Nevertheless, under physi-
ological conditions in the ER lumen the native substrates for
H6PDH are believed to be G6P and NADP+ [21]. These ﬁnd-
ings indicate that the enzyme has no access to cytosolic NAD+,
sugars and sugar phosphates, except G6P, which is transported
by the speciﬁc G6PT [8].4. Oxidative protein folding and antioxidant metabolism
Luminal proteins and luminal domains of membrane pro-
teins of the ER contain remarkably more disulﬁde bridgesand less thiol groups than the cytosolic ones. This diﬀerent
[protein thiol]/[protein disulﬁde] ratio is also reﬂected by a dif-
ferent [GSH]/[GSSG] ratio, which is nearly 100:1 in the cytosol
and about 1:1 in the ER lumen [4]. Such a high potential dif-
ference and concentration gradient would be hard to maintain
if the membrane was permeable to both GSH and GSSG. The
ﬁnding that isolated hepatic microsomes still contain GSH and
GSSG [22] strongly suggested that the ER membrane repre-
sents a barrier for these molecules. Indeed, the ER membrane
is impermeable to GSSG while GSH has a slow protein-
mediated transport [23]. Therefore, locally oxidized GSH is
entrapped in the form of GSSG in the lumen, contributing
to the maintenance of the oxidizing environment in the
compartment.
Luminal thiol oxidation is facilitated by ascorbate (vitamin
C) [24] or FAD [5,25]; so the physiological role of their trans-
port has been proposed. ER membrane is selectively permeable
to dehydroascorbate, the oxidized form of ascorbate [26,27].
Luminal reduction of dehydroascorbate to ascorbate is associ-
ated with thiol oxidation and leads to an ascorbate entrapment
[28].
FAD uptake and a consequent thiol oxidation have also
been found in yeast and liver microsomes [5,25]. In contrast
to FAD, pyridine nucleotides – NADP(H), NAD(H) – of sim-
ilar size and structure cannot enter the ER lumen at a signiﬁ-
cant rate, which is indicated by the high latency of intraluminal
H6PDH and 11bHSDH1 [16] and by direct transport measure-
ments [19].
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The major second-phase reaction of hepatic biotransforma-
tion is glucuronidation that takes place in the ER (Fig. 1).
Transfer of glucuronosyl group from UDP-glucuronate
(UGA) to appropriate functional groups of the substrates is
catalyzed by UDP-glucuronosyltransferases (UGTs). These
enzymes are integral membrane proteins of the ER with their
active center localized in the lumen [29]. UGA is synthesized
in the cytosol and the produced glucuronides are pumped
out of the cell by plasma membrane transporters. Thus conju-
gation with glucuronate requires UGA import [30] and glucu-
ronide export across the ER membrane. It has been
demonstrated, using photoaﬃnity-labeling technique, that
UGA but not UDP-glucose has access to the active center of
UGTs in intact microsomal vesicles [31]. The high (more than
90%) latency of UGTs observed both in microsomal vesicles
and isolated permeabilized hepatocytes indicates that trans-
port processes (presumably UGA uptake) are rate limiting
[32,33]. Activity of the intraluminal b-glucuronidase, a glucu-
ronide-cleaving enzyme, is also limited by substrate (glucuro-
nide) transport, although it has a smaller (approximately
40%) latency [34] (Fig. 1).
Protein-mediated glucuronide transport across the ER mem-
brane has been demonstrated [35], and competition for the
transport has been found between glucuronides of similar size
[36]. The pattern of interactions suggested the presence of mul-
tiple glucuronide transporters with overlapping speciﬁcities in
the ER membrane [36].6. The transporter associated with antigen processing (TAP)
Beside G6PT, TAP peptide transporter – belonging to the
superfamily of ABC transporters – is the only ER transporter
characterized at molecular level. Oligopeptides (approx. 8–16
amino acids of length) produced by the proteasome in the
cytosol are translocated by the heterodimer of TAP1 and
TAP2 to the ER lumen, where they bind to major histocom-
patibility complex (MHC) class I molecules. MHC-peptide
complexes leave the ER by vesicular transport and reach the
cell surface for recognition by cytotoxic T lymphocytes. Loss
of TAP function leads to an impairment of antigen presenta-
tion, as it is commonly observed in tumors and virus-infected
cells that escape immune surveillance [37]. This condition
clearly shows that basal permeability of the ER membrane
does not allow the appearance of these small oligopeptides in
the lumen.7. Translocon and permeability of rough ER (RER) membrane
Abundance of channels may theoretically contribute to a
general permeability or leakiness of the ER membrane. This
has been demonstrated in case of ribosome-bound translocon
complex, which co-translationally imports nascent peptides
into the RER lumen [38]. The average diameter of translocon
tunnel is approximately 20 A˚, which is suﬃciently wide to al-
low transport of Ca2+ [39] and small water-soluble molecules
[40]. Therefore, the presence of translocon complexes might
be responsible for higher permeability of rough versus smooth
ER membrane [38].Unspeciﬁc permeability is prevented in the translationally
active translocon because the tunnel is occupied by the peptide
chain being polymerized. Similarly, the pore is blocked by BiP
proteins, prominent intraluminal chaperones, after dissocia-
tion of the ribosome from the complex [41]. In fact, it has been
argued that the BiP lock forms smaller barrier for uncharged
polar molecules than for charged ones. Furthermore, dissocia-
tion of ribosomes from translocon complexes is delayed after
the termination of protein synthesis. When a non-translating
ribosome is associated to translocon complex, they form a
transitional low-selectivity channel between the cytosol and
the ER lumen [42].8. Conclusion
The proposed general, non-speciﬁc permeability of the ER
membrane is clearly incompatible with several experimental
ﬁndings and physiological or pathological observations.
The collected data provide suﬃcient evidence for the pres-
ence of a barrier between the cytosol and the ER lumen. This
barrier gives rise to generation of a characteristic micro-envi-
ronment in the lumen with a higher Ca2+ concentration and
with a more oxidized GSH redox-buﬀer. It also plays role in
the modulation of certain ER-associated activities by limiting
the accessibility of luminal enzymes to their substrates and –
by this means – it contributes to their speciﬁcity as well. On
the other hand, compared with the plasma membrane or some
other cellular membranes, the ER membrane – especially the
RER membrane – is relatively permeable, in terms of allowing
detectable penetration of a number of investigated molecules.
The huge diﬀerence between the diﬀusion rates of similar
compounds, as well as the existence of substances apparently
unable to permeate provide convincing evidence that low-
speciﬁcity transporters rather than a leaky lipid bi-layer are
responsible for the phenomenon.
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